Legal, Regulatory Matters and Contingencies (Details)				1 Months Ended				2 Months Ended	6 Months Ended
	Jan. 14, 2020 USD ($)	May 22, 2019 USD ($)	May 10, 2019 company employee	Oct. 31, 2019 item	Aug. 31, 2019 USD ($)	Dec. 31, 2016 company	Nov. 30, 2016 item	Jun. 30, 2019 USD ($)	Dec. 31, 2019 USD ($) Distributor lawsuit tranche state	Dec. 31, 2019 product	Dec. 31, 2019 USD ($)	Jun. 18, 2018 product	Jun. 07, 2018 product	Oct. 31, 2017 product	Oct. 06, 2017 product
Legal, Regulatory Matters and Contingencies
Settlement payment									$ 9,400,000
Reimbursement of overpayment									$ 8,100,000
State Attorneys General Inquiry into The Generic Pharmaceutical Industry
Legal, Regulatory Matters and Contingencies
Number of drugs | product														13
Number of officers | employee			1
Number of manufacturers and distributors | company			33			6
State Attorneys General Inquiry into The Generic Pharmaceutical Industry | Doxycycline Monohydrate
Legal, Regulatory Matters and Contingencies
Number of drugs | product														1
Government Pricing
Legal, Regulatory Matters and Contingencies
Settlement payment		$ 9,400,000
Reimbursement of overpayment					$ 8,100,000
Private Antitrust and Consumer Protection Litigation
Legal, Regulatory Matters and Contingencies
Number of drugs										18	18	15	14		6
Number of manufacturers and distributors | Distributor									30
Number of lawsuits | lawsuit									100
Number of Tranches | tranche									3
Number of States | state									49
Shareholder Litigation
Legal, Regulatory Matters and Contingencies
Number of officers | item				2			2
Litigation settlement amount payable to other party	$ 600,000							$ 300,000